Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica Frau

Showing results (1-10 of 103) with videos related to

Pageof 11
Sort By:
Drug Design, Development and Therapy|May 19, 2021
An Overview of the Efficacy and Safety of Ozanimod for the Treatment of Relapsing Multiple SclerosisMarzia Fronza, Lorena Lorefice, Jessica Frau, et al.
Frontiers in Immunology|October 25, 2021
Infections and Multiple Sclerosis: From the World to Sardinia, From Sardinia to the WorldJessica Frau, Giancarlo Coghe, Lorena Lorefice, et al.
Neuropsychiatric Disease and Treatment|May 3, 2018
New horizons for multiple sclerosis therapeutics: milestones in the development of ocrelizumabJessica Frau, Giancarlo Coghe, Lorena Lorefice, et al.
Life (Basel, Switzerland)|June 28, 2023
The Role of Microorganisms in the Etiopathogenesis of Demyelinating DiseasesJessica Frau, Giancarlo Coghe, Lorena Lorefice, et al.
Inflammation & Allergy Drug Targets|February 1, 2014
Monoclonal antibodies: a target therapy for multiple sclerosisLorena Lorefice, Giuseppe Fenu, Jessica Frau, et al.
Scientific Reports|March 10, 2016
Epstein Barr Virus and Mycobacterium avium subsp. paratuberculosis peptides are recognized in sera and cerebrospinal fluid of MS patientsGiuseppe Mameli, Eleonora Cocco, Jessica Frau, et al.
Plos One|July 24, 2020
Optical coherence tomography angiography in multiple sclerosis: A cross-sectional studyRoberta Farci, Arturo Carta, Eleonora Cocco, et al.
International Journal of Environmental Research and Public Health|December 2, 2020
Does Multiple Sclerosis Differently Impact Physical Activity in Women and Man? A Quantitative Study Based on Wearable AccelerometersMassimiliano Pau, Micaela Porta, Giancarlo Coghe, et al.
Journal of Neurology|March 14, 2019
Efficacy and safety of alemtuzumab in a real-life cohort of patients with multiple sclerosisJessica Frau, Giancarlo Coghe, Lorena Lorefice, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|March 13, 2024
Ocrelizumab use in multiple sclerosis: a real-world experience in a changing therapeutic scenarioLorena Lorefice, Paolo Mellino, Jessica Frau, et al.
Pageof 11

Showing results (1-10 of 103) with videos related to

Sort By:
Pageof 11
Drug Design, Development and Therapy|May 19, 2021
An Overview of the Efficacy and Safety of Ozanimod for the Treatment of Relapsing Multiple SclerosisMarzia Fronza, Lorena Lorefice, Jessica Frau, et al.
Frontiers in Immunology|October 25, 2021
Infections and Multiple Sclerosis: From the World to Sardinia, From Sardinia to the WorldJessica Frau, Giancarlo Coghe, Lorena Lorefice, et al.
Neuropsychiatric Disease and Treatment|May 3, 2018
New horizons for multiple sclerosis therapeutics: milestones in the development of ocrelizumabJessica Frau, Giancarlo Coghe, Lorena Lorefice, et al.
Life (Basel, Switzerland)|June 28, 2023
The Role of Microorganisms in the Etiopathogenesis of Demyelinating DiseasesJessica Frau, Giancarlo Coghe, Lorena Lorefice, et al.
Inflammation & Allergy Drug Targets|February 1, 2014
Monoclonal antibodies: a target therapy for multiple sclerosisLorena Lorefice, Giuseppe Fenu, Jessica Frau, et al.
Scientific Reports|March 10, 2016
Epstein Barr Virus and Mycobacterium avium subsp. paratuberculosis peptides are recognized in sera and cerebrospinal fluid of MS patientsGiuseppe Mameli, Eleonora Cocco, Jessica Frau, et al.
Plos One|July 24, 2020
Optical coherence tomography angiography in multiple sclerosis: A cross-sectional studyRoberta Farci, Arturo Carta, Eleonora Cocco, et al.
International Journal of Environmental Research and Public Health|December 2, 2020
Does Multiple Sclerosis Differently Impact Physical Activity in Women and Man? A Quantitative Study Based on Wearable AccelerometersMassimiliano Pau, Micaela Porta, Giancarlo Coghe, et al.
Journal of Neurology|March 14, 2019
Efficacy and safety of alemtuzumab in a real-life cohort of patients with multiple sclerosisJessica Frau, Giancarlo Coghe, Lorena Lorefice, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|March 13, 2024
Ocrelizumab use in multiple sclerosis: a real-world experience in a changing therapeutic scenarioLorena Lorefice, Paolo Mellino, Jessica Frau, et al.
Pageof 11